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A B S T R A C T
The effect of cerebral amyloidosis on cerebral hemodynamics was investigated with photoacoustic
tomography (PAT) and magnetic resonance imaging (MRI). First, the sensitivity and robustness of PAT for
deriving metrics of vascular and tissue oxygenation in the murine brain was assessed in wild-type mice
with a hyperoxia-normoxia challenge. Secondly, cerebral oxygenation was assessed in young and aged
arcAb mice and wild-type controls with PAT, while cerebral blood ﬂow (CBF) was determined by
perfusion MRI. The investigations revealed that PAT can sensitively and robustly detect physiological
changes in vascular and tissue oxygenation. An advanced stage of cerebral amyloidosis in arcAb mice is
accompanied by a decreases in cortical CBF and the cerebral metabolic rate of oxygen (CMRO2), as oxygen
extraction fraction (OEF) has been found unaffected. Thus, PAT constitutes a robust non-invasive tool for
deriving metrics of tissue oxygenation, extraction and metabolism in the mouse brain under
physiological and disease states.
© 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The brain has a very high demand for oxygen compared to other
organs (it utilizes approximately 20% of the body’s total oxygen
consumption), making tight regulation of cerebral blood ﬂow (CBF)
and oxygen delivery critical for brain function [1]. The regional
quantiﬁcation of oxygen saturation (SO2), brain oxygen extraction
fraction (OEF) and, in conjunction with perfusion imaging for CBF,
the cerebral metabolic rate of oxygen (CMRO2) are key measures of
brain hemodynamic function. Quantiﬁcation of these parameters
has helped to elucidate brain functional physiology and holds
translational potential as a clinical tool for evaluating neurological
disorders such as stroke, brain tumors and Alzheimer’s disease
(AD) and other age-related pathologies.
AD is associated with vascular dysfunction which partakes in the
pathogenesis of the disease [2]. Patients with AD show regional
hypoperfusion, decreased levels of oxygenated hemoglobin (HbO2)
andtissueoxygenation[3],aswellascapillarydysfunctionatanearly
disease stage, reported to be associated with cognitive symptom
severity and neurodegeneration [4]. 15O PET study in AD patients
showed reduced CMRO2 compare to healthy controls [5]. Transgenic
mice overexpressing human amyloid precursor protein (APP) are
widely used models of AD. These mice display progressive
amyloidosis in the brain and enable studying the inﬂuence of
amyloid-beta (Ab) accumulation on vascular function [6]. In APP
mice hypoperfusion and capillary dysfunction [7] have been
described, but the relationships to oxygen transport and metabolism
have not yet been investigated. Moreover, methods which are non-
invasive possess a high sensitivity and spatial resolution, cover a
large ﬁeld-of-view and are easy to apply are highly desired.
In recent years, a variety of biological and medical imaging
techniques have been developed to assess cerebral oxygenation in
animal models and in humans. Positron emission tomography (PET)
with 15O is considered the gold standard for the whole-brain
oxygenation measurement in clinical setting [8]. While the method
has been applied to mice [9], the method suffers from low spatial
resolution which limits its usefulness for studying small species
Moreover, the short half-life of [15O] requires an on-site cyclotron,
which restricts the widespread use of this approach. Alternatively,
MRI-based techniques such as blood oxygenation level-dependent
(BOLD), quantitative BOLD, susceptometry, T2-relaxation-under-
spin-tagging and 17O MR spectroscopy among others have been
proposed for mapping oxygenation [10]. Measurements of BOLD and
CBF in conjunction with hypercapnic or hyperoxic respiratory
challenges have been proposed for measuring relative changes and
absolute value of CMRO2 [11]. However MR methods that infer the
regional concentration of oxygen by measuring tissue R2, R2’ or R2*
relaxation rates (such as BOLD) or bulk susceptibility, which is
* Corresponding author at: Institute for Biomedical Engineering, University of
Zurich and ETH Zurich, Valdimir-Prelog-Weg 4, 8093 Zurich, Switzerland.
E-mail address: klohs@biomed.ee.ethz.ch (J. Klohs).
https://doi.org/10.1016/j.pacs.2018.04.001
2213-5979/© 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
Photoacoustics 10 (2018) 38–47
Contents lists available at ScienceDirect
Photoacoustics
journal homepage: www.else vie r .com/ locate /pacs
sensitive to paramagnetic compounds such as Hb, are prone to
confounder as non-vascular tissue compartments invariably con-
tribute to the signals or are sensitive to changes in vessel caliber and
orientation. This limits their applicability for characterizing brain
diseases that involve signiﬁcant remodeling of the vasculature such
as in arcAb mouse model [12–14].
Optical imaging such as Doppler optical coherence tomography
[15], laser Doppler spectroscopy [16], two-photon [17], near-
infrared spectroscopy [18], photoacoustic microscopy [19,20], and
single-impulse panoramic photoacoustic computed tomography
[21] have been used for deriving metrics of regional tissue
oxygenation in small animals; yet these techniques, are often
invasive, or suffer from a small ﬁeld-of-view and limited depth
penetration. By using multiple wavelengths for illuminating and
spectral unmixing algorithms, photoacoustic tomography (PAT)
resolves signal contribution from different photoabsorbing mol-
ecules in tissue simultaneously based on their spectral properties
[22]. In biological tissue major absorbers such as hemoglobin
serves as an endogenous contrast agent for PAT [23,24]. As
hemoglobins display signiﬁcant absorption values in the red and
near-infrared spectral domain, PAT allows the non-invasive
assessment of hemodynamic parameters relatively deep in tissue
(mm range) [25] in the brains of rats and mice [26].
Here we describe an approach to estimate OEF and CMRO2 in
mouse brain based on PAT estimates of arterial oxygen saturation
(SaO2) in the middle cerebral artery (MCA) and venous oxygen
saturation (SvO2) in the superior sagittal sinus (SSS) as well as in
cortical tissue oxygenation (StO2) of mouse in combination with CBF
measurements by using perfusion magnetic resonance imaging
(MRI). We found reduced cortical CBF in aged transgenic arcAb mice,
which displays abundant parenchymal and vascular amyloid
deposition [24,27]. Due to the inability of the vascular system to
compensate the decrease in oxygen delivery by increasing the OEF,
CMRO2 values were found to be signiﬁcantly decreased.
2. Methods
2.1. Animal model
Ten female non-transgenic C57BL/6 mice (12 weeks) were
purchased from Janvier (France) and used in the oxygen-challenge
PAT validation experiment for deriving SaO2 in the MCA, SvO2 in the
SSS and StO2 in the cortical tissue. Eighteen transgenic arcAb mice
overexpressing the human APP695 transgene containing the
Swedish (K670N/M671L) and arctic (E693G) mutation under the
control of the prion protein promoter and eighteen age-matched
non-transgenic C57BL/6 littermates of both sexes were bred at
Phenomic Center ETH Zurich (Switzerland) and were assessed at 6-
and 24-months of age. ArcAb mice are characterized by Ab plaque
formation at 6-months of age together with a pronounced cerebral
amyloid angiopathy [27]. Animals were housed in ventilated cages
inside a temperature-controlled room, under a 12-h dark/light
cycle. Pelleted food (3437PXL15, CARGILL) and water were
provided ad-libitum. Using StatMate (Graphpad prism 7.0, USA)
a sample size of n = 6 per group was calculated a priory for the
primary end point CBF, a ﬁxed effect omnibus, one-way ANOVA
with four groups, and an effect size f = 0.78, a = 0.05 and b = 0.2.
Consequently, group sizes n > 6 were used.
2.2. Perfusion MRI protocol
MRI was performed on a 7/16 small animal MR Pharmascan
(Bruker Biospin GmbH, Ettlingen, Germany) equipped with an
actively shielded gradient set of 760 mT/mwith a 80 ms rise time and
operated by a Paravision 6.0 software platform (Bruker Biospin
GmbH, Germany). We used a circular polarized volume resonator for
signal transmission and an actively decoupled mouse brain
quadrature surface coil with integrated combiner and preampliﬁer
for signal receiving (Bruker BioSpin, Germany). Thirty-three mice
were anesthetized with an initial dose of 4% isoﬂurane (Abbott,
Cham, Switzerland) in oxygen/air (200:800 mL/min) mixture in the
induction box and were maintained at 1.5% isoﬂurane in oxygen/air
(100:400 mL/min) mixture supplied via a nose cone. Mice were
placed in prone position on a water-heated support to keep body
temperature at 36.5  0.5 C monitored with a rectal temperature
probe. T2-weighted anatomical reference images were acquired in
coronal and sagittal orientations and served for accurate positioning
of the arterial spin labeling(ASL)slice (Fig. 3A). A spin-echo sequence
was used with rapid acquisition relaxation enhancement, echo
time = 33 ms; relaxation time = 2500 ms; rapid acquisition relaxa-
tion enhancement factor = 8; ﬂip angle = 90; ﬁfteen sagittal slices of
1 mm thickness; ﬁeld-of-view = 20  20 mm; image ma-
trix = 256  256; spatial resolution = 78  78 mm; resulting in an
acquisition time of 2 min 40 s.
Perfusion was measured under resting conditions using an ASL
method with a ﬂow sensitive alternating inversion recovery
technique. Fieldmap-based shimming was performed using the
automated MAPshim routine to improve the homogeneity of the
magnetic ﬁeld. A spin-echo planar imaging sequence preceded by a
180 hyperbolic secant RF inversion pulse was used with echo
time = 12.47 ms; relaxation time = 12000 ms; ﬂip angle = 90. One
axial slide of 1 mm thickness was acquired approximately at Bregma
1.46 mm with a ﬁeld-of-view = 20  20 mm; image ma-
trix = 128  96, with a spatial resolution = 156 mm  208 mm. Inver-
sion parameters were: inversion slab thickness = 4 mm, slice
margin = 1.5 mm. Sixteen images with increasing inversion times
(10 s, 50–3000 ms) were obtained for T1 calculations, with a total scan
time of 11 min and 55 s. Inversion recovery data from the imaging
slices was acquired after selective inversion interleaved with non-
selective inversion. For each mouse brain in the current study, a T2-
weighted anatomical image was acquired at the same position as the
ASL slice for drawing regions of interest (ROI). Paxinos mouse brain
atlas was used as the anatomical reference for scan and analysis.
2.3. PAT and image paradigm
For PAT the inVision 128 small animal multi-spectral opto-
acoustic tomography system (iThera Medical GmbH, Munich,
Germany) was used as described before [28]. We ﬁrst tested the
sensitivity and repeatability of PAT for detecting physiological
changes in blood and tissue oxygenation by applying an oxygen
challenge. Longitudinal PAT measurements were performed in 10
wild-type mice for 15 min. Mice were anesthetized with an
oxygen/air mixture (200:800 mL/min) in the induction box and
anesthesia was maintained at 1.5% isoﬂurane supplied via a nose
cone under normal air supply (oxygen/air 100:400 mL/min). The
hyperoxia challenge consists of two cycles: normoxia (oxygen/air
0:500 mL/min, fraction of inspired oxygen FiO2 = 20%, 3 min) –
100% hyperoxia (oxygen/air 500:0 mL/min, FiO2 = 100%, 3 min)
during continuous imaging were performed based on previous
photoacoustic microscopy setting [21] as illustrated in Fig. 1 and
Supplementary Fig. 1. The paradigm allowed us to compare the
repeatability of the approach (comparing test and retest values).
The body temperature of the mouse was kept at 36.5 C while
imaging by adjusting the temperature of the water chamber. Laser
excitation pulses of 9 ns were delivered at ﬁve wavelengths (715,
730, 760, 800, 850 nm); one coronal slice was examined, 1 average
was collected [28]. Data were acquired continuously for 15 min
resulting in 360 frames for each mouse corresponding to an
acquisition time of 2.5 s per image frame.
In the second part of the study we assessed the capability of
PAT to detect alteration in oxygen saturation, extraction and
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metabolism due to amyloid pathology. Metrics of vascular and
tissue oxygenation were derived from multi-spectral PAT
measurements of arcAb (n = 17) and wild-type (n = 16) mice of
6-months and 24-months of age. Mice were anesthetized with an
oxygen/air mixture (200:800 mL/min) in the induction box and
anesthesia maintained with 1.5% isoﬂurane in oxygen/air
(100:400 mL/min) via a nose cone. Imaging was performed at
ﬁve wavelengths 715, 730, 760, 800, 850 nm on coronal slices, with
10 averages per slice. Rostral caudal brain coverage extended over
a length of approximately 12 mm with a step size of 0.3 mm
resulting 40 slices. Data acquisition time was 4 min.
Fig. 1. In vivo brain oxygen saturation in wild-type mice under oxygen challenge with photoacoustic tomography. Representative coronal SO2 map derived from PAT
measurements of Hb and HbO2 of a head of a wild-type mouse under (A) hyperoxic and (B) normoxic conditions, approximatly Bregma 1.5  0.3 mm; overlaid with T2-
weighted magnetic resonance image (C) DSO2 map to show differences in oxygenation in hyperoxia-normoxia challenge; (D) Cortical StO2 and SvO2 derived from PAT
measurements during normoxia (grey region) and hyperoxia in brain of wild-type mice (n = 10); (E) Signiﬁcant differences between cortical StO2 and SvO2 under normoxia
and hyperoxia condition. Mann-Whitney Rank Sum Test, *** p < 0.001; StO2: tissue oxygen saturation; SaO2: arterial oxygen saturation SvO2: venous oxygen saturation.
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2.4. Perfusion MRI data analysis
ROIs were drawn over the cerebral cortex and thalamus on axial
T2-weighted anatomical scans and then transferred to the CBF
maps using AFNI (NIH, USA, Fig. 3A). For CBF calculation, the ﬂow
sensitive alternating inversion recovery images with different
T1selective were realigned and resliced over the ﬁrst T1 using a rigid-
body model. Determination of T1selective and T1global were
performed by ﬁtting the averaged signal intensities in each ROIs
with 3-parameters mono-exponential T1 relaxation curve. CBF in
ROIs was calculated from both T1 values using the Eq. (1) in
MATLAB R2015b (Mathworks, MA, USA):
CBF=l ¼ T1global
T1blood
1
T1selective
 1
T1global
 
ð1Þ
where CBF is the amount of blood passing through the brain tissue
in mL/100 g/min, l is the blood/tissue partition coefﬁcient for
water, assumed to be 0.9 mL/g [29] and T1blood was assumed to be
2.007 s at 7 T [30].
2.5. PAT data post-processing and analysis
PAT images were reconstructed using a model linear algorithm
with a non-negativity constraint imposed during inversion. Linear
unmixing was applied to resolve signals from Hb/HbO2. Six C57BL/
6 mice with prominent dark pigment on their skin over the head
which interferes with PAT measurements were excluded from data
analysis. PAT images were co-registered and overlaid with T2-
weighted MRI scans using a landmark-based registration with
Matlab (R2015a, Mathworks, USA) (https://codeocean.com/
Fig. 2. Physiological parameters estimated by oximetry during oxygen challenge. (A-E) Time course of peripheral oxygen saturation (%), breath distention (mm), pulse
distention (mm), heart rate (beat per min, bpm), respiratory rate (breath rate per min, brpm) measured under normoxia (grey region, 3–6 and 9–12 min) and hyperoxia (0–3,
6–9 and 12–15 min) in wild-type mice (n = 10); F) Signiﬁcant difference between peripheral oxygen saturation% under normoxia and hyperoxia. Mann-Whitney Rank Sum
Test, ***p < 0.0001;.
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algorithm/910653cc-f008-4573-9b8c-92dde419528c/code) as de-
scribed previously [31]. Firstly, the anatomical PAT image was
aligned with the T2-weighted MR image and 6–7 pairs of
anatomical landmarks were manually selected. Secondly, non-
reﬂective similarity transformation was applied to PAT images
after processing MR images calculated based on the least square
algorithm of the landmark pairs in both PAT and MR images.
Rotation, scaling and transformation were applied during regis-
tration. As PAT images of Hb, HbO2 share the same coordinates
with the intrinsic anatomical images, the same co-registration
transformation was applied to the Hb, HbO2 and the computed SO2
images. The resulting images were overlaid on the T2-MRI images
in multiple channels. ROIs were drawn over the axial overlaid PAT/
MR images using ImageJ (NIH, U.S.A.). As the vessels have a
diameter of 140 mm, on coronal cross-sections of the mouse head,
circular ROIs of diameter 140 mm, area 0.0049 mm2 were
delineated at MCA for calculating SaO2; and at SSS for calculating
SvO2 on the computed SO2 image. ROIs with an area of approx.
24 mm2were delineated over the cortex for quantifying tissue StO2
(illustrated in Fig. 1A). Values for oxygen saturation in tissue and
large vessel (StO2 or Sa/vO2) was calculated according to:
SiO2 ¼ HbO2;i= Hbi þ HbO2ið Þ  100 ð2Þ
With i = t,a, v. PAT will resolve absolute values of SiO2 if the
recorded signal is directly related to the absorbed optical energy
distribution, with knowledge of the light ﬂuence distribution,
system response and Grüneisen parameter [32,33]. Thus the values
derived in this study represent metrics of the PAT measurements
rather than absolute SO2 values.
The OEF values were obtained as:
OEF ¼ SaO2  SvO2ð Þ=SaO2 ð3Þ
and hyperoxia induced change in tissue oxygenation as:
DSiO2 ¼ hyperoxia SiO2  hypoxia SiO2 ð4Þ
With SiO2 deﬁned in Eq. (2). As SiO2 values became stable within
two min after switching the oxygen concentration of the gas
supply (Fig. 2), the values measured during the ﬁnal min of each
three-min interval were used for calculating the mean
(hyperoxia SiO2 ) or (hyperoxia SiO2 ) and differences in oxygen
saturation (DSO2). Maps of SO2, DSO2, DHb and DHbO2 for
hyperoxia challenge were calculated using ImageJ (NIH, U.S.A.). The
SO2 images computed directly from HbO2/Hb image were used for
validation of SO2 values derived from ROI analysis of the Hb and
HbO2 map. Based on the Fick’s principle, CMRO2 can be derived
from the arteriovenous oxygen gradient:
CMRO2 ¼ CBF  SaO2  SvO2ð Þ  Ca ð5Þ
Where Ca is a constant representing the maximal amount of oxygen
carrying capacity of a unit volume of blood at a hematocrit of 0.44,
assumed to be 833.7 mmol O2/100 mL blood [34].
2.6. Physiological monitoring
The physiological conditions of ten wild-type mice in oxygen
challenged PAT measurement were monitored using MouseOx Plus
oximeter (Starr Life Science, U.S.A.). Breathe distention, pulse
distention, heart rate, percentage of peripheral oxygen saturation
and breath rate were recorded every 30 s over 15 min with the
same oxygen challenge and anesthesia paradigm using an infrared
sensor which was placed on the shaved upper hind limb of the
wild-type mice (n = 10).
2.7. Statistics
All data are present as mean  standard deviation (SD). One-
way ANOVA with post hoc Bonferroni correction for multiple
comparisons was used for group analysis (Graphpad Prism 6.0, CA,
U.S.A). A non-parametric Mann-Whitney Rank Sum test was used
for group comparison. The reproducibility of PAT measures of
DSO2, quantiﬁed by using the Pearson correlation analysis of the
value obtained at test and retest (n = 10). The correlation between
CBF and CMRO2 was analyzed using the Person correlation
analysis. Signiﬁcance was set at * p < 0.05, ** p < 0.01, *** p < 0.001.
3. Results
3.1. Sensitivity and repeatability of PAT for detecting physiological
changes in blood oxygenation
Alterations in Hb and HbO2 during an oxygen challenge were
measured using PAT in cortical tissue, the MCA and the SSS of 12-
weeks-old wild-type mice. From those measurements mean values
of DSO2 and were calculated for each condition based on the ﬁnal
min within the 3-min challenge after a stable state was reached.
Fig. 3. Regional hypoperfusion in aged arcAb mice. (A) Anatomical position of perfusion MRI and T2-weighted scan on the sagittal view of the anatomical reference image and
representative regions of interest (cortex (red) and thalamus (blue)) on coronal T2-weighted anatomical image acquired at the same position as the ASL slice; (B)
Representative coronal CBF map (approximatly Bregma 1.5  0.3 mm) of 6- and 24-months-old wild-type littermate (upper row, n = 8, 7) and arcAb mice (lower row, n = 8,
8); (C) Reduced CBF in the cortex of 24-months old arcAb compared with age-matched wild-type mice; Reduced CBF in the cortex of arcAb mice at 24-months compared to 6-
months. *p < 0.05, one-way ANOVA with post hoc Bonferroni correction for multiple comparison; CBF, cerebral blood ﬂow; ASL, arterial spin labeling.
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The time course of delta changes, representative four coronal maps
for normoxic and hyperoxic conditions are shown in the
Supplementary Fig. 1. During hyperoxia higher levels of HbO2
and correspondingly reduced values for Hb have been found in all
compartments analyzed when compared to the normoxic refer-
ence: values for HbO2 were 16.95  1.51 vs 16.45  0.47 a.u.
(p < 0.001) for cortical tissue, 29.55  1.57 vs 25.10  0.69 a.u.
(p < 0.001) for the SSS, and 7.18  0.98 vs 6.46  0.32 a.u.
(p < 0.001) for the MCA; while values for Hb were 17.14  1.81
vs 18.60  0.72 a.u. (p < 0.001)) for the cortical tissue, 6.54  1.41 vs
10.82  1.13 a.u. (p < 0.001) for the SSS, and 0.01  0.01 vs
0.14  0.05 a.u. (p < 0.001) during hyperoxia vs normoxia for the
MCA respectively.
Maps of SO2 and a DSO2 were derived from PAT measure-
ments of Hb and HbO2. Fig. 1A–C shows a representative coronal
SO2 and a DSO2 map co-registered with T2-weighted MRI images
of a wild-type mouse during oxygen challenge. Both cortical StO2
and SvO2 with normoxia (3–6 and 9–12 min) and hyperoxia (0–3,
6–9 and 12–15 min) revealed a robust increase in oxygenation
during hyperoxia (Fig. 1C), while changes detected were smaller
in SaO2 values. Hyperoxia led to a signiﬁcant increase in cortical
StO2 from 47.38  0.42% to 50.51  0.71% (p < 0.001) and of SvO2
from 75.32  1.13 % to 86.67  1.18 % (p < 0.001) compared to
normoxia, whereas the respective arterial value were SaO2
99.37  0.93 % to 99.66  0.34 % (non-signiﬁcant) (Fig. 1D,E).
The OEF was calculated according to Eq. (3) for the two
oxygenation states of the mouse brain. The OEF was decreased
almost 50 % under hyperoxic conditions as compared to normoxia
(0.13  0.05 vs 0.24  0.06).
The reproducibility of the PAT estimates of SaO2 and SvO2 were
analyzed by Pearson correlation of test and retest values
(Supplementary Fig. 2). Robust correlation was observed between
the test-retest values of the entire measurement session including
3-min hyperoxia and 3 min normoxia for mean SvO2 (r = 0.9007,
Fig. 4. In vivo assessment of brain oxygenation with PAT in arcAb mice. (A, B) SO2maps of arcAb and wild-type mice at 6- and 24-month (coronal view, approximately Bregma
1.5  0.3 mm); (b) ROIs are drawn over the middle cerebral artery (MCA) and superior sagittal sinus (SSS), scale bar = 1.5 mm images overlaid on T2-weighted anatomical
image; (C) Quantiﬁcation of OEF and (D) CMRO2 (mmol/g/min) in the brain of arcAb and wild-type at 6-months and 24-months. CMRO2 is lower in the 24-month arcAb mouse
compared to wild-type and 6-months arcAb mice. OEF does not signiﬁcantly differ in the brain of wild-type and arcAb mice of both ages (n = 6-8 per group); Results are
Mean  SD, *,#p < 0.05, one way ANOVA with post hoc correction for multiple comparison; CMRO2, cerebral oxygen metabolic rate; OEF, oxygenation extraction fraction; SO2,
oxygen saturation.
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p < 0.0001) and mean SaO2 (r = 0.2721, p = 0.0010) of the ten wild-
type mice. Correlation of the test-retest value of each mouse was
also observed for SvO2 under normoxia (r = 0.949, p < 0.0001) and
hyperoxia (r = 0.8662, p = 0.0012). Due to small variation in the
value of SaO2 (close to 1), no correlation was observed for the test-
retest comparison of each mouse.
Physiological parameters and peripheral oxygen saturation of
mice were monitored on the mouse hind limb using an oximeter
for 15 min under the same oxygen supply paradigm and anesthesia
conditions as during the PAT measurement (Fig. 2). The peripheral
StO2 assessed by oximetry signiﬁcantly increased by 0.9% under
hyperoxia compared to normoxia (97.74  0.16% vs 96.85  0.27%,
p < 0.0001). No statistically signiﬁcant differences were observed
in heart rate, breath distention, pulse distention and breath rate
between two breathing conditions.
3.2. Age dependent reduction of CBF in the cortex of arcAb mice by
using perfusion MRI
CBF-MRI measurements were performed with ASL in arcAb and
wild-type mice of both 6- and 24-months of age to assess age-
dependent differences in cerebral perfusion due to Ab deposition
and cerebral amyloid angiopathy. ROI analysis of CBF MRI maps
showed similar levels of CBF in the cortex and thalamus between
arcAb and wild-type mice at 6-months of age (Fig. 3A–C). A 30%
reduction of CBF was observed in the cortex of arcAb mice at 24-
months compared to aged-matched wild-type mice, while the
levels of CBF in the thalamus were not signiﬁcantly different
between groups. There was no age-related effect on brain
perfusion in wild-type animals: similar CBF values have been
obtained for 6-months and 24-months mice both in the cortical
and thalamic ROIs.
3.3. Reduced CMRO2 values in arcAb mice compared to wild-type
littermates
We used PAT to determine the OEF and calculate CMRO2 using
the CBF derived from perfusion MRI in 6 months- and 24-month
old arcAb mice and the corresponding age-matched littermates
under normoxic conditions (FiO2 36%). PAT covered a brain volume
of 8 mm in rostral caudal direction. Fig. 4A shows the SO2 in the
coronal section of the brain of wild-type and arcAb mice at 6- and
24-month of age. PAT measured OEF values derived from Sa/vO2 did
not differ between 24-months arcAb mice (0.18  0.04, n = 8), age-
matched wild-type mice (0.16  0.06, n = 7), 6-months arcAb
(0.16  0.04, n = 7) and wild-type mice (0.14  0.02, n = 7) (Fig. 4B–
C). Correspondingly, the calculated CMRO2 values were lower in
the 24-months arcAb mice (1.81  0.64 a.u., n = 7) compared to
age-matched wild-type mice (2.8  0.67 a.u., n = 5, p = 0.0338) and
6-months arcAb (2.7  0.8 a.u., n = 7, 0.0346). In contrast, the
CMRO2 did not differ between the 6-months arcAb and wild-type
mice (2.30  0.27 a.u., n = 7). The CMRO2 correlated with CBF in
arcAb and wild-type mice (*** p < 0.0001, r = 0.6987, n = 26), and
within arcAb and mice (*** p < 0.0006, r = 0.7975, n = 14).
4. Discussion
PAT constitutes an attractive alternative to PET and MRI for non-
invasive assessment of metrics of brain oxygenation and metabo-
lism with whole brain coverage and high spatial resolution in mice.
The technique exploits the absorption spectrum of hemoglobin,
which depends on the oxygen concentration. Previous studies have
used photoacoustic imaging and tomography to measure hemo-
dynamic parameters such as CBF, cerebral blood volume, vessel
diameter, total, deoxy- and oxygenated hemoglobin, and thus
oxygen saturation in large vessels at resting state and during
functional stimulation in the brain of mice [35–37]. In this study
we identiﬁed individual large blood vessels such as the MCA which
has a vessel diameter of approximately 140 mm [38] and the SSS.
Our PAT system did not allow assessing oxygenation in the
microvasculature, which is below the spatial resolution of 150 mm.
However, photoacoustic microscopy has been used to provide
hemodynamic measures down to the capillary level, though such
systems have the trade-off of lower penetration depth and/or are
invasive [19,20]. The PAT measures of metrics of SaO2 and SvO2
derived from measurements of Hb and HbO2 of the artery and vein
under normoxia of 99.37% and 75.32% found in the current study
are similar to the values of 98  100% and 80  89% for arterial and
venous blood respectively, as reported previously [19,39]
It should be noted that PAT does not provide absolute
quantiﬁcation of SO2 due to several factors: First, signiﬁcant light
absorption in the brain and extracerebral tissue affects the incident
light ﬂuence and hence the detected signal amplitude [33]. We
have shown previously that measurements of Hb and HbO2 are
limited to a depths of 4–5 mm [31]. Hence, for absolute
quantiﬁcation ﬂuence correction and knowledge of the Grüneisen
parameter [32,33] characterizing the thermoexpansion is required.
Secondly, the light attenuation by tissue (or any absorber) depends
on the absorption spectrum, i.e. the relative contribution of tissue
depth layers to the signal will vary across the spectrum. Calibration
of the attenuation may improve quantiﬁcation of oxygenation [41].
The repetition of the hyperoxia-normoxia challenge demon-
strated good reproducibility of the results (Supplementary Fig. 2).
The high temporal resolution of (2.5 s) of the method revealed an
equilibration time of 2 min upon changing the oxygen level of the
inspiration gas, largely reﬂecting physiological adaptation. Calcu-
lation of mean SO2 values at steady state showed that a hyperoxic
challenge increases SaO2 by only 0.3%. This is due to the fact that
arteries are already highly oxygenated under normoxic conditions.
Therefore SaO2 can only modestly increase in comparison to veins
where SvO2 is lower, in line with previous reports [42]. Measured
increases of 10-13% in venous SvO2 have been reported [37,39]
comparable to our result of a 13% increase. The change in StO2 was
6.5%, and reﬂects an averaged StO2 value comprising arterial,
venous and capillary contributions. Thus, increasing the oxygen
level in the inspiration gas from 20 to 100% gave rise to only a 3.13%
increase in cortical StO2. In the periphery, the change in StO2 was
estimated to be 0.9% using a mouse oximeter. Our study, in line
with previous reports demonstrates that PAT yields robust and
reproducible metrics of blood and tissue oxygenation. While
absolute values of Hb and HbO2 may vary even under identical
experimental conditions, the SO2 values derived from these
measurements were found to be highly reproducible (Supplemen-
tary Figs. 1 and 2).
Estimation of measures of oxygen metabolism such as OEF and
CMRO2 requires knowledge of CBF. Several photoacoustic methods
have been proposed to measure CBF using photoacoustic
microscopy [43]. However, such a method was not implementable
with our current PAT system. We opted to use ASL MRI to assess
cerebral perfusion as the method yields quantitative CBF values
and is applicable in a straightforward manner also in humans. Co-
registering of maps of Hb and HbO2 with T2-weighted MR images
yielded an anatomical reference for ROIs delineation, where
speciﬁc brain regions are more difﬁcult to delineate. The arcAb and
littermate cohorts were measured in slightly hyperoxic (i.e. FiO2
36%) conditions due to the mixture of the breathing gas we used for
anesthesia. In littermates, cortical OEF and CMRO2 values of  0.16
and 2.6-2.7 mmol/g/min have been derived, in accordance with
values from the literature measured with 15O PET and 17O MR
spectroscopy [44–46] and photoacoustic microscopy [19]. Aging
has been reported to decrease both OEF and CMRO2 in the brain of
humans [47,48]. This was not observed in our study: we did not
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ﬁnd any statistically signiﬁcant difference in measures of OEF and
CMRO2 in wild-type mice of 6- and 24-months of age. However,
CMRO2 but not OEF was found to be signiﬁcantly decreased in
arcAb mice at 24-months of age. While animals at 6-months of age
are devoid of parenchymal amyloid plaques, 24-months old mice
display widespread parenchymal plaque deposition as well as
vascular amyloid pathology [12,27]. This indicates that the reduced
CMRO2 in these mice is not an age-effect but is rather associated
with the advanced amyloid pathology. We found that cortical CBF
measured by perfusion MRI was reduced in 24-months old arcAb
mice, which under physiological conditions would result in an
increase in OEF. Yet OEF values in these animals were similar to
those found in wild-type mice and 6-months old arcAb mice. This
indicates that the cortical hypoperfusion observed during the
advanced disease stage is not compensated by an adaptation of OEF
in order to maintain CMRO2 within the normal range or the
metabolisms of the brain is compromised. CBF correlated with
CMRO2 values.
Previous studies in APP mouse models of AD have assessed
cerebral perfusion but not cerebral oxygen metabolism. A reduced
regional CBF was reported for strains with cerebral amyloid
angiopathy deposition such as APP23, Tg2576, APP DSL, APPswe/
PS1DE9 mice, but not in APP/PS1 mouse without cerebral amyloid
angiopathy burden, indicating a strong contribution of cerebral
amyloid angiopathy to the perfusion deﬁcit [49–53]. Earlier studies
from our group showed age-related vascular remodeling and
signiﬁcant reduced density of functional intracortical microvessels
of arcAb mice [14], which has also strong cerebral amyloid
angiopathy, and impaired vascular reactivity in the cortex but not
in the subcortical regions [54]. Reduced CBF and increased OEF have
been reported in patients with AD [3,55], and there is an increasing
awareness that vascular and metabolic alternations play an
important role in the pathogenesis of AD [56]. At an early stage, a
loss of cerebral perfusion pressure, which would result in decreased
CBF, is compensated by an increase in cerebral blood volume. As
cerebral autoregulation becomes increasingly compromised, de-
creasing CBF values will be counteracted by increases in OEF to
maintain CMRO2 in physiological range. Brain hypoperfusion and
low oxygen availability can affect brain protein synthesis, lead to
neuronal dysfunction [2], and an increase in APP processing, thus
aggravating Ab deposition [57]. At an advanced disease stage, this
compensatory mechanism becomes exhausted leading to tissue
hypoxia ischemia, which ultimately will translate into loss of
neurons and tissue damage and thus a reduced CMRO2. Hence,
hemodynamic parameters in AD might be important read-outs for
disease staging and for monitoring therapeutic interventions
targeting vascular dysfunction.
There are several limitations in this study: 1) ROIs drawn for the
MCA and SSS are inevitably small because of the spatial resolution
of our PAT system. It is expected that a system with a higher
resolution will provide a better accuracy of the signal measure-
ments. 2) We computed OEF and CMRO2 only for the cortex. The
brain region is mainly supplied by the MCA and drained via cortical
veins that connect to the SSS, vessels that could be easily identiﬁed
on the Hb/HbO2 and SO2 maps. Other brain regions might be more
difﬁcult to assess e.g. the thalamus is supplied by smaller
branching arteries, some of which originated from the internal
carotid artery and posterior cerebral artery, which we currently
cannot resolve with PAT. 3) Anesthesia affects cerebral oxygen
metabolism: a recent study showed a dose-dependent decrease in
OEF and CMRO2 during isoﬂurane anesthesia in comparison to
comparison to awake animals [19]. As a result, the measured values
of OEF and CMRO2 are likely to be higher when measured in wake
mice. While this may affect the quantitative comparison of OEF and
CMRO2 values in wild-type and arcAb mice, it would not affect the
qualitative result, i.e. that aged arcAb mice display reduced CMRO2
values. 4) The technique is not easily translatable for human
imaging. While application in some tissue such as the skin, breast
[58], abdomen for Crohn's Disease [59] and tumor [60] has been
demonstrated already, application to the human brain is difﬁcult,
hampered by the presence of the skull.
5. Conclusion
OurresultsshowthatPATcanderivemetricsofSO2insinglefeeding
and draining vessels and cortical tissue. PAT can sensitively and
robustly detect physiological changes in blood oxygenation as
demonstrated in oxygen challenge experiments. Furthermore, the
approach can yield in conjunction with CBF derived from perfusion
MRI, measures of brain oxygen metabolism. Application into
transgenic arcAb mice showed that at advanced disease stage
involving cerebral amyloidosis and cerebral amyloid angiopathy
corticalperfusionbecomessigniﬁcantlydecreased.Duetotheinability
of the vascular system to compensate the decrease in oxygen delivery
by increasing the OEF, CMRO2 values were found to be signiﬁcantly
decreased, likely putting the tissue under hypoxic stress.
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